Peripheral PD-1(+) T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection

Direct acting antiviral (DAA) regimens of 12 weeks result in HCV clearance in vast majority of patients across genotypes. We previously demonstrated an ultra-short regimen of 4 weeks DAA cleared HCV in a subset of patients. Here, we hypothesized that individual level of antiviral immunity differenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Romani, Sara, Stafford, Kristen, Nelson, Amy, Bagchi, Shashwatee, Kottilil, Shyam, Poonia, Bhawna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610534/
https://www.ncbi.nlm.nih.gov/pubmed/31316516
http://dx.doi.org/10.3389/fimmu.2019.01470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610534/
https://www.ncbi.nlm.nih.gov/pubmed/31316516
http://dx.doi.org/10.3389/fimmu.2019.01470

Ejemplares similares